Cargando…

Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients

BACKGROUND: There is a lack of clinical data on the validity of neoadjuvant chemotherapy in the treatment of ovarian cancer. The aim of this study was to compare the impact of the adjuvant and neoadjuvant chemotherapy regimens on the clinical outcomes in patients with advanced ovarian cancer. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inciura, Arturas, Simavicius, Andrius, Juozaityte, Elona, Kurtinaitis, Juozas, Nadisauskiene, Ruta, Svedas, Eimantas, Kajenas, Skirmantas
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533845/ https://www.ncbi.nlm.nih.gov/pubmed/16759398 http://dx.doi.org/10.1186/1471-2407-6-153

Ejemplares similares

Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene
por: Žilienė, Eglė, et al.
Publicado: (2023)

Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma: A prospective randomised study
por: Rudzianskiene, Milda, et al.
Publicado: (2017)

Corticosteroid-Responsive Pulmonary Toxicity Associated with Fludarabine Monophosphate: A Case Report
por: Rudzianskiene, Milda, et al.
Publicado: (2012)

Mitochondria-related TFAM gene variants and their effects on patients with cervical cancer
por: Golubickaite, Ieva, et al.
Publicado: (2021)

POLG Gene Variants in Cervical Cancer Patients and Their Associations with Clinical and Pathomorphological Tumor Characteristics
por: Golubickaite, Ieva, et al.
Publicado: (2021)

TIRAP Rs8177376, Rs611953, Rs3802814, and Rs8177374 Polymorphisms and Their Association with Cervical Cancer Phenotype and Prognosis
por: Bekampytė, Justina, et al.
Publicado: (2022)

Laparoscopic sentinel lymph node mapping with indocyanine green in endometrial cancer: surgeon’s learning curve (cumulative sum analysis)
por: Gedgaudaite, Migle, et al.
Publicado: (2023)

Duffy and Kidd Genotyping Facilitates Pretransfusion Testing in Patients Undergoing Long-Term Transfusion Therapy
por: Remeikiene, Diana, et al.
Publicado: (2014)

Digital Phenotyping for Monitoring and Disease Trajectory Prediction of Patients With Cancer: Protocol for a Prospective Observational Cohort Study
por: Jenciūtė, Gabrielė, et al.
Publicado: (2023)

Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients
por: Liutkauskiene, Sigita, et al.
Publicado: (2015)

Memorandum 574
por: CERN. Geneva. SPS-LEAR Experiments Committee
Publicado: (1996)

Thrombotic risk assessment in 185 WHO-defined essential thrombocythemia patients: single center experience
por: Dambrauskiene, Ruta, et al.
Publicado: (2015)

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2017)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
por: Yang, Chang, et al.
Publicado: (2020)

The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone
por: Grigienė, Rūta, et al.
Publicado: (2007)

The Feasibility of Sentinel Lymph-Node, Mapped with Indocyanine Green, Biopsy in Endometrial Cancer Patients: A Prospective Study
por: Gedgaudaite, Migle, et al.
Publicado: (2022)

Cancer mortality differences among urban and rural residents in Lithuania
por: Smailyte, Giedre, et al.
Publicado: (2008)

Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer
por: Meghal, Trishala, et al.
Publicado: (2019)

Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes
por: Liutkauskiene, Sigita, et al.
Publicado: (2018)

Association of angiogenesis and inflammation-related gene functional polymorphisms with early-stage breast cancer prognosis
por: Korobeinikova, Erika, et al.
Publicado: (2020)

Feasibility of neoadjuvant and adjuvant intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer: A single-center experience
por: Liu, Yu, et al.
Publicado: (2020)

Diagnosis of HELLP Syndrome: A 10-Year Survey in a Perinatology Centre
por: Rimaitis, Kestutis, et al.
Publicado: (2019)

Is adjuvant chemotherapy better than neoadjuvant chemotherapy for those with node positive disease?
por: Zabell, Joseph, et al.
Publicado: (2018)

Use of Adjuvant Chemotherapy in Patients with Advanced Bladder Cancer after Neoadjuvant Chemotherapy
por: Sui, Wilson, et al.
Publicado: (2017)

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
por: Patel, Ami, et al.
Publicado: (2021)

Abstract 11. The Effect of Neoadjuvant Chemotherapy Compared to Adjuvant Chemotherapy in Nipple-Sparing Mastectomy
por: Frey, Jordan D., et al.
Publicado: (2017)

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

Clinical Outcome of Hereditary Breast Cancer in the Lithuanian Population
por: Elsakov, Pavel, et al.
Publicado: (2005)

574 The Impact of Age on Wound Healing Progression in Burns
por: Pignet, Anna-Lisa, et al.
Publicado: (2023)

Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
por: McFerrin, Coleman, et al.
Publicado: (2020)

Increasing thyroid cancer incidence in Lithuania in 1978–2003
por: Smailyte, Giedre, et al.
Publicado: (2006)

Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians
por: Kupcinskas, Juozas, et al.
Publicado: (2011)

Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
por: Dambrauskienė, Rūta, et al.
Publicado: (2023)

574 Want some s’more? The hidden risks of marshmallows
por: Ghini, Francesca, et al.
Publicado: (2022)

Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy
por: RUDZIANSKAS, V., et al.
Publicado: (2012)

Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion
por: Eldefrawy, Ahmed, et al.
Publicado: (2012)

Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patients
por: URAKAWA, HIROSHI, et al.
Publicado: (2014)

Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma
por: Torrigiani, Filippo, et al.
Publicado: (2019)

Interstitial lung disease associated with adjuvant and neoadjuvant chemotherapy in early breast cancer
por: Tezuka, Kenji, et al.
Publicado: (2021)

Neoadjuvant versus Adjuvant Chemotherapy in Patients with Resectable Muscle-Invasive Bladder Cancer
por: Sawasdee, Anupong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2761rqe9geknqok7phv3vqkj2d